INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE

THE PRESENT INVENTION RELATES TO COMPOUNDS THAT INHIBIT SERINE PROTEASE ACTIVITY, PARTICULARLY THE ACTIVITY OF HEPATITIS C VIRUS NS3-NS4A PROTEASE. AS SUCH, THEY ACT BY INTERFERING WITH THE LIFE CYCLE OF THE HEPATITIS C VIRUS AND ARE ALSO USEFUL AS ANTIVIRAL AGENTS. THE INVENTION FURTHER RELATES TO...

Full description

Saved in:
Bibliographic Details
Main Authors SHAWN D. BRITT, JOHN J. COURT, ROBERT B. PERNI, JOHN H. VAN DRIE, JANOS PITLIK
Format Patent
LanguageEnglish
Published 28.02.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract THE PRESENT INVENTION RELATES TO COMPOUNDS THAT INHIBIT SERINE PROTEASE ACTIVITY, PARTICULARLY THE ACTIVITY OF HEPATITIS C VIRUS NS3-NS4A PROTEASE. AS SUCH, THEY ACT BY INTERFERING WITH THE LIFE CYCLE OF THE HEPATITIS C VIRUS AND ARE ALSO USEFUL AS ANTIVIRAL AGENTS. THE INVENTION FURTHER RELATES TO COMPOSITIONS COMPRISING THESE COMPOUNDS EITHER FOR EX VIVO USE OR FOR ADMINISTRATION TO A PATIENT SUFFERING FROM HCV INFECTION. THE INVENTION ALSO RELATES TO METHODS OF TREATING AN HCV INFECTION IN A PATIENT BY ADMINISTERING A COMPOSITION COMPRISING A COMPOUND OF THIS INVENTION. THE INVENTION FURTHER RELATES TO PROCESSES FOR PREPARING THESE COMPOUNDS.
AbstractList THE PRESENT INVENTION RELATES TO COMPOUNDS THAT INHIBIT SERINE PROTEASE ACTIVITY, PARTICULARLY THE ACTIVITY OF HEPATITIS C VIRUS NS3-NS4A PROTEASE. AS SUCH, THEY ACT BY INTERFERING WITH THE LIFE CYCLE OF THE HEPATITIS C VIRUS AND ARE ALSO USEFUL AS ANTIVIRAL AGENTS. THE INVENTION FURTHER RELATES TO COMPOSITIONS COMPRISING THESE COMPOUNDS EITHER FOR EX VIVO USE OR FOR ADMINISTRATION TO A PATIENT SUFFERING FROM HCV INFECTION. THE INVENTION ALSO RELATES TO METHODS OF TREATING AN HCV INFECTION IN A PATIENT BY ADMINISTERING A COMPOSITION COMPRISING A COMPOUND OF THIS INVENTION. THE INVENTION FURTHER RELATES TO PROCESSES FOR PREPARING THESE COMPOUNDS.
Author SHAWN D. BRITT
JOHN H. VAN DRIE
JANOS PITLIK
ROBERT B. PERNI
JOHN J. COURT
Author_xml – fullname: SHAWN D. BRITT
– fullname: JOHN J. COURT
– fullname: ROBERT B. PERNI
– fullname: JOHN H. VAN DRIE
– fullname: JANOS PITLIK
BookMark eNrjYmDJy89L5WRw8vTz8HTyDPEPClbwd1MIdg3y9HNVCAjyD3F1DHYN1lEIcAwK8XQO9XEM8olU8HAOU_ALNtb1CzZxhCviYWBNS8wpTuWF0twMcm6uIc4euqkF-fGpxQWJyal5qSXxvpGGJhaGRsaOxgQVAAAgJyvg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID MY148123A
GroupedDBID EVB
ID FETCH-epo_espacenet_MY148123A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:54:20 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_MY148123A3
Notes Application Number: MY2004PI03610
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130228&DB=EPODOC&CC=MY&NR=148123A
ParticipantIDs epo_espacenet_MY148123A
PublicationCentury 2000
PublicationDate 20130228
PublicationDateYYYYMMDD 2013-02-28
PublicationDate_xml – month: 02
  year: 2013
  text: 20130228
  day: 28
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies VERTEX PHARMACEUTICALS INCORPORATED
RelatedCompanies_xml – name: VERTEX PHARMACEUTICALS INCORPORATED
Score 2.8786504
Snippet THE PRESENT INVENTION RELATES TO COMPOUNDS THAT INHIBIT SERINE PROTEASE ACTIVITY, PARTICULARLY THE ACTIVITY OF HEPATITIS C VIRUS NS3-NS4A PROTEASE. AS SUCH,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130228&DB=EPODOC&locale=&CC=MY&NR=148123A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3NT4MwFH-Z06g3nTo_lx4MJ4nKRzcPxECBgHFABlu20wKjGC9scRj_fR8Nm152a9qmeW3ye-_Xvo8C3OepRlWFq_KgoJmsqZkuD9JnKutF2keDofAFF1G-AfXG2ttUn7bgY5MLI-qE_ojiiIioBeK9Evp69feIZYvYyvVj9oldy1c3MWypuR3XXjhlINmW4UShHTKJMWM4k4KRgawfdbS5B_vIofs1FJyJVaekrP7bE_cEDiJcqqxOocXLDhyxzbdrHTgcNt5ubDbAW5-B5Qeeb_lJOIpJ6JK4rgTlkGgUJo6JGvGBREhMfTZ-N5GcEo9NSBCrchBr5nbSOfRcJ2GejMLMt9ueD2eN0OoFtMtlyS-B6C96kSMEF09FrqF9yxSODIyqOeV5TvXiCro7FrneOXIDx4r446HO076FdvX1ze_Q0lZZT5zSL1frfl8
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3JTsMwEB2Vgig3KPtSfEA5EQFZTDhEKKsSaBY1adWeqqZxEJe0okH8PhMrLVx6s2xrNLY0M8-eDeAunylUlpgsagXNREXOVFGbPVFRLWbPaDAkNmc8yjek3lB5G6vjFnysc2F4ndAfXhwRJWqO8l5xfb38-8SyeWzl6iH7xKnFq5vqttC8jmsvnKQJtqk7cWRHlmBZejARwoGOqB91tLEDu4ivtbrVgTMy65SU5X974h7CXoykyuoIWqzsQsdat13rwn7QeLtx2Aje6hhMP_R800-jQUIilyR1JSiHxIModQzUiPckRmDqW8O-geCUeNaIhIksholibDadQM91UssTkZnp5tjTYNIwLZ9Cu1yU7ByI-qIWOYrg_LHIFbRvmcQQgVE5pyzPqVpcwNkWIpdbV26h46VBf9r3w_crOJB4v4c6Z_sa2tXXN7tBq1tlPX5jv2zbgU8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=INHIBITORS+OF+SERINE+PROTEASES%2C+PARTICULARLY+HCV+NS3-NS4A+PROTEASE&rft.inventor=SHAWN+D.+BRITT&rft.inventor=JOHN+J.+COURT&rft.inventor=ROBERT+B.+PERNI&rft.inventor=JOHN+H.+VAN+DRIE&rft.inventor=JANOS+PITLIK&rft.date=2013-02-28&rft.externalDBID=A&rft.externalDocID=MY148123A